According to the Evaluate consultancys 2026 Preview report, Mounjaro and Zepbound are projected to collectively generate more than $45 billion in global sales in 2026, overtaking Mercks Keytruda to become the worlds best-selling drug
doi: 10.1002/pds.3837 19 DriessenJHvan den BerghJPvan OnzenoortHAHenryRMLeufkensHGde VriesF
GLP-1 Medications and Plastic Surgery: What You Need to Know Go Back At Straith Clinic, patient safety has always been at the center of everything we do
Confirming that you have no personal or family history of medullary thyroid cancer and no symptoms suggesting existing thyroid disease matters far more than serial laboratory testing during therapy
They should not be used by: People with a history of pancreatitis (inflammation of the pancreas) Anyone with a personal or family history of medullary thyroid cancer (a rare type of thyroid cancer) People with multiple endocrine neoplasia type 2 (MEN 2, a rare inherited condition that raises the risk of certain hormone-related tumors, including thyroid cancer) Women who are pregnant or breastfeeding People with severe stomach or bowel problems, such as gastroparesis (slow stomach emptying that causes nausea, fullness, or vomiting) or inflammatory bowel disease (chronic inflammation of the digestive tract, such as Crohns disease or ulcerative colitis) Those with severe kidney problems, especially with certain types of GLP-1 medicines, such as exenatide Anyone with allergies to GLP-1 medications or who has had a severe reaction to them Use in children is limited to certain GLP-1 medicines approved for adolescents with obesity
